Durvalumab,BA3011,BA3021
BioAtla,Astrazeneca
['ovarian']
today at #asco23 cctg ind240 (cri-cctg-0003) poster for an immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (iproc) poster session tps5617: 
The Canadian Cancer Trials Group is a cancer clinical trials research cooperative that runs phase I-III trials to test anti-cancer and supportive therapies.